Commonwealth Equity Services LLC Has $350,000 Stock Holdings in Doximity, Inc. (NASDAQ:DOCS)

Commonwealth Equity Services LLC lowered its stake in Doximity, Inc. (NASDAQ:DOCS) by 40.3% during the second quarter, according to the company in its most recent filing with the Securities & Exchange Commission. The firm owned 12,531 shares of the company’s stock after selling 8,472 shares during the quarter. Commonwealth Equity Services LLC’s holdings in Doximity were worth $350,000 at the end of the most recent reporting period.

Other institutional investors have also made changes to their positions in the company. iA Global Asset Management Inc. increased its stake in Doximity by 36.5% in the second quarter. iA Global Asset Management Inc. now owns 44,683 shares of the company’s stock valued at $1,250,000 after purchasing an additional 11,946 shares in the last quarter. Zurcher Kantonalbank Zurich Cantonalbank grew its stake in Doximity by 5.9% in the second quarter. Zurcher Kantonalbank Zurich Cantonalbank now owns 23,528 shares of the company’s stock valued at $658,000 after acquiring an additional 1,303 shares during the period. Bank of New York Mellon Corp increased its holdings in shares of Doximity by 1.5% in the second quarter. Bank of New York Mellon Corp now owns 1,144,748 shares of the company’s stock worth $32,019,000 after acquiring an additional 17,430 shares in the last quarter. EFG Asset Management North America Corp. raised its position in shares of Doximity by 56.0% during the second quarter. EFG Asset Management North America Corp. now owns 82,347 shares of the company’s stock worth $2,303,000 after purchasing an additional 29,566 shares during the period. Finally, Lecap Asset Management Ltd. bought a new position in shares of Doximity during the 2nd quarter valued at about $625,000. 87.19% of the stock is owned by institutional investors and hedge funds.

Doximity Stock Up 1.5 %

Shares of NASDAQ DOCS opened at $41.50 on Tuesday. The business’s 50 day moving average price is $33.47 and its two-hundred day moving average price is $29.10. Doximity, Inc. has a twelve month low of $19.71 and a twelve month high of $41.69. The company has a market cap of $7.70 billion, a PE ratio of 57.64, a price-to-earnings-growth ratio of 5.15 and a beta of 1.27.

Doximity (NASDAQ:DOCS) last released its quarterly earnings results on Thursday, August 8th. The company reported $0.22 EPS for the quarter, topping analysts’ consensus estimates of $0.16 by $0.06. Doximity had a net margin of 32.53% and a return on equity of 19.26%. The business had revenue of $126.68 million for the quarter, compared to analyst estimates of $119.88 million. As a group, research analysts anticipate that Doximity, Inc. will post 0.8 EPS for the current fiscal year.

Insider Buying and Selling at Doximity

In other news, CFO Anna Bryson sold 30,000 shares of the stock in a transaction on Friday, August 9th. The stock was sold at an average price of $35.00, for a total transaction of $1,050,000.00. Following the sale, the chief financial officer now directly owns 309,627 shares of the company’s stock, valued at approximately $10,836,945. The transaction was disclosed in a legal filing with the SEC, which is accessible through the SEC website. In other news, CFO Anna Bryson sold 30,000 shares of the company’s stock in a transaction that occurred on Friday, August 9th. The shares were sold at an average price of $35.00, for a total transaction of $1,050,000.00. Following the completion of the sale, the chief financial officer now owns 309,627 shares of the company’s stock, valued at approximately $10,836,945. The sale was disclosed in a legal filing with the SEC, which is accessible through this hyperlink. Also, Director Watkin Phoebe L. Yang sold 1,940 shares of the stock in a transaction that occurred on Monday, July 29th. The stock was sold at an average price of $28.22, for a total transaction of $54,746.80. Following the sale, the director now owns 12,269 shares in the company, valued at approximately $346,231.18. The disclosure for this sale can be found here. Insiders sold 37,951 shares of company stock valued at $1,271,018 in the last three months. Corporate insiders own 39.40% of the company’s stock.

Analyst Upgrades and Downgrades

Several analysts have commented on DOCS shares. Truist Financial restated a “hold” rating and set a $35.00 target price (up from $31.00) on shares of Doximity in a report on Wednesday, August 14th. Wells Fargo & Company cut Doximity from an “equal weight” rating to an “underweight” rating and lowered their target price for the stock from $27.00 to $19.00 in a report on Thursday, July 18th. JPMorgan Chase & Co. upped their price objective on Doximity from $27.00 to $30.00 and gave the stock a “neutral” rating in a research report on Monday, August 19th. Needham & Company LLC raised Doximity from a “hold” rating to a “buy” rating and set a $38.00 target price on the stock in a research report on Friday, August 9th. Finally, Robert W. Baird raised their price target on shares of Doximity from $41.00 to $45.00 and gave the stock an “outperform” rating in a research note on Tuesday, September 17th. Two research analysts have rated the stock with a sell rating, eight have assigned a hold rating, four have given a buy rating and one has issued a strong buy rating to the company. According to data from MarketBeat.com, Doximity currently has a consensus rating of “Hold” and an average price target of $32.42.

Doximity Company Profile

Doximity, Inc operates a cloud-based digital platform for medical professionals in the United States. The company's platform provides its members with tools built for medical professionals, enabling them to collaborate with their colleagues, coordinate patient care, conduct virtual patient visits, stay up to date with the latest medical news and research, and manage their careers.